Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TGF-βRII regulates glucose metabolism in oral cancer-associated fibroblasts via promoting PKM2 nuclear translocation. | Cell Death Discov | 2022 | 35013150 | PubTator, text mining | PubMed |
| Trophoblast-derived Lactic Acid Orchestrates Decidual Macrophage Differentiation via SRC/LDHA Signaling in Early Pregnancy. | Int J Biol Sci | 2022 | 35002512 | PubTator, text mining | PubMed |
| The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis. | Cell Mol Immunol | 2022 | 34983946 | PubTator, text mining | PubMed |
| Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment. | JCI Insight | 2022 | 34941573 | PubTator, text mining | PubMed |
| Pyruvate metabolism guides definitive lineage specification during hematopoietic emergence. | EMBO Rep | 2022 | 34914165 | PubTator, text mining | PubMed |
| Targeting cancer metabolism in the era of precision oncology. | Nat Rev Drug Discov | 2022 | 34862480 | PubTator, text mining | PubMed |
| Machine learning based predictive model and systems-level network of host-microbe interactions in post-COVID-19 mucormycosis. | Microb Pathog | 2022 | 34861346 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of HPV(+) Oropharyngeal Squamous Cell Carcinoma Recurrence. | J Proteome Res | 2022 | 34846153 | PubTator, text mining | PubMed |
| Development of a one-plasmid system to replace the endogenous protein with point mutation for post-translational modification studies. | Mol Biol Rep | 2022 | 34762224 | PubTator, text mining | PubMed |
| Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1. | J Ethnopharmacol | 2022 | 34737010 | PubTator, text mining | PubMed |
| High-Plex Spatial RNA Profiling Reveals Cell Type‒Specific Biomarker Expression during Melanoma Development. | J Invest Dermatol | 2022 | 34699906 | PubTator, text mining | PubMed |
| Proteomic Signatures of Human Visceral and Subcutaneous Adipocytes. | J Clin Endocrinol Metab | 2022 | 34669916 | PubTator, text mining | PubMed |
| Lactate shuttle: from substance exchange to regulatory mechanism. | Hum Cell | 2022 | 34606041 | PubTator, text mining | PubMed |
| Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study. | Rev Clin Esp (Barc) | 2022 | 34556435 | PubTator, text mining | PubMed |
| Pyruvate-Driven Oxidative Phosphorylation is Downregulated in Sepsis-Induced Cardiomyopathy: A Study of Mitochondrial Proteome. | Shock | 2022 | 34506367 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of exhaled breath condensate between lung adenocarcinoma and CT-detected benign pulmonary nodule patients. | Cancer Biomark | 2022 | 34334381 | PubTator, text mining | PubMed |
| [Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study]. | Rev Clin Esp | 2022 | 34054133 | PubTator, text mining | PubMed |
| Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy. | Mol Oncol | 2022 | 34050611 | PubTator, text mining | PubMed |
| Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2/FAK/SOX6 signaling pathway in nasopharyngeal carcinoma. | Cell Biol Toxicol | 2022 | 33797657 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension. | Cell Mol Neurobiol | 2022 | 33594519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=48